CDC Tracks 'Cicada' COVID Variant's Rapid U.S. Rise Amid Mutation Concerns

The SARS-CoV-2 BA.3.2 variant, nicknamed 'Cicada' for its pattern of emergence and disappearance like the insects, was first detected in a South African respiratory sample on November 22, 2024.[1][3][5] It boasts 70 to 75 mutations and deletions in its spike protein compared to the JN.1 lineage and its descendant LP.8.1, the targets of current COVID-19 vaccines, raising fears of immune escape.[2][3][4] By February 11, 2026, BA.3.2 had appeared in 23 countries, with weekly detections hitting 30% of sequences in Denmark, Germany, and the Netherlands from November 2025 to January 2026.[2][3] In the U.S., the variant entered via a traveler from the Netherlands on June 27, 2025, confirmed through the CDC's Traveler-Based Genomic Surveillance program.[2][3] It has since shown up in nasal swabs from four travelers, clinical samples from five patients, three airplane wastewater samples, and 132 wastewater surveillance samples across 25 states, per the CDC's Morbidity and Mortality Weekly Report published last week.[1][2][3] Wastewater data from Stanford University's WasteWaterSCAN reveals a sharp climb: from less than 4% of U.S. cases in mid-March to more than 20% by early April 2026.[1] Clinically, its prevalence stood at 0.19% among 2,579 sequences collected since December 1, 2025, though some reports peg it at 11% in recent wastewater tracking.[3][6] Dr. Marc Siegel, Fox News senior medical analyst, called BA.3.2 'concerning' due to its heavy mutations, noting it represents a new lineage distinct from dominant JN.1 strains like LP.8.1 and XFG since January 2024.[2] Two sublineages, BA.3.2.1 and BA.3.2.2, signal ongoing evolution.[2] Globally, it accounts for about 8% of variants, per the World Health Organization.[4] The CDC first flagged it in mid-March when it was minimal, but detections rose from September 2025, with the first U.S. clinical case on January 5, 2026.[1][3] No surge in hospitalizations or severe cases has emerged yet, despite the mutations.[4] Experts like Vanderbilt's William Schaffner warn of a possible late spring or early summer spike, echoing past U.S. summer waves.[6] The CDC emphasizes continued genomic surveillance via wastewater, travelers, and national sequencing to track its path and inform vaccine updates, as new variants have historically driven case surges by evading prior immunity.[5] As of early April 2026, officials have not reinstated mask mandates but urge vigilance in high-risk settings.